Treatments for combined small cell lung cancer patients
Jiaxi He(Johnson & Johnson (United States)), Jianxing He(First Affiliated Hospital of Guangzhou Medical University), Songhui Xu(Nanchang University), Shuben Li(National Clinical Research Center for Digestive Diseases), Hui Pan(National Clinical Research Center for Digestive Diseases)
Cited by 22
Related Papers
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry
|Journal of Clinical Oncology|2017|358
Choice of Surgical Procedure for Patients With Non–Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study
|Journal of Clinical Oncology|2016|245
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183
Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells
|Proceedings of the National Academy of Sciences|2018|107
Association between serum leptin levels and breast cancer risk
|Medicine|2018|103